HMGN2 Antikörper (pSer29)
Kurzübersicht für HMGN2 Antikörper (pSer29) (ABIN7181590)
Target
Alle HMGN2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pSer29
-
Verwendungszweck
- Phospho-HMGN2 (S29) Antibody
-
Kreuzreaktivität
- Maus, Ratte
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from Human HMG-17 around the phosphorylation site of S29.
-
Isotyp
- IgG
-
-
anti-High Mobility Group Nucleosomal Binding Domain 2 (HMGN2) (AA 2-81) antibody
HMGN2 Reaktivität: Human IHC, WB, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-High Mobility Group Nucleosomal Binding Domain 2 (HMGN2) antibodyHMGN2 Reaktivität: Human IHC, WB, IF, ICC, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-High Mobility Group Nucleosomal Binding Domain 2 (HMGN2) antibodyHMGN2 Reaktivität: Human, Ratte, Maus IHC, WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-High Mobility Group Nucleosomal Binding Domain 2 (HMGN2) (Internal Region) antibodyHMGN2 Reaktivität: Human, Ratte, Maus IHC, ELISA, WB, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-High Mobility Group Nucleosomal Binding Domain 2 (HMGN2) (AA 1-90) antibodyHMGN2 Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-High Mobility Group Nucleosomal Binding Domain 2 (HMGN2) antibodyHMGN2 Reaktivität: Human IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-High Mobility Group Nucleosomal Binding Domain 2 (HMGN2) (N-Term) antibodyHMGN2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-High Mobility Group Nucleosomal Binding Domain 2 (HMGN2) (AA 1-90) antibodyHMGN2 Reaktivität: Human ELISA, WB Wirt: Maus Polyclonal unconjugated
anti-High Mobility Group Nucleosomal Binding Domain 2 (HMGN2) (N-Term) antibodyHMGN2 Reaktivität: Human, Ratte, Maus, Hund, Schwein, Pferd, Fledermaus, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-High Mobility Group Nucleosomal Binding Domain 2 (HMGN2) (AA 1-30), (N-Term) antibodyHMGN2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB37401 unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- HMGN2 (High Mobility Group Nucleosomal Binding Domain 2 (HMGN2))
-
Andere Bezeichnung
- HMGN2
-
Hintergrund
- High mobility group (nonhistone chromosomal) protein 17 antibody, high mobility group nucleosomal binding domain 2 antibody, High mobility group nucleosome-binding domain-containing protein 2 antibody, High mobility group protein N2 antibody, HMG17 antibody, HMGN2 antibody, HMGN2_HUMAN antibody, MGC5629 antibody, Non histone chromosomal protein HMG 17 antibody, Non-histone chromosomal protein HMG-17 antibody, Nonhistone chromosomal protein HMG 17 antibody, nonhistone chromosomal protein hmg-17 antibody
-
UniProt
- P05204
Target
-
